These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25133049)

  • 1. Rhabdomyolysis after midazolam administration in a cirrhotic patient treated with atorvastatin.
    Gigante A; Giraldi GD; Gasperini ML; Barbano B; Liberatori M; Sardo L; Mario FD; Giorgi A; Rossi-Fanelli F; Amoroso A
    World J Gastrointest Pharmacol Ther; 2014 Aug; 5(3):196-9. PubMed ID: 25133049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose atorvastatin therapy induced rhabdomyolysis in a liver cirrhosis patient - a case report.
    Bhattarai S; Pradhan SR; Bhattarai S
    Ann Med Surg (Lond); 2023 Oct; 85(10):5232-5234. PubMed ID: 37811121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    Lewin JJ; Nappi JM; Taylor MH
    Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis in an elderly multitreated patient: multiple drug interactions after statin withdrawal.
    Ginanneschi F; Volpi N; Giannini F; Rocchi R; Donati D; Aglianò M; Lorenzoni P; Rossi A
    J Neurol Sci; 2014 Jan; 336(1-2):284-7. PubMed ID: 24252882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
    Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
    Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin safety: lessons from new drug applications for marketed statins.
    Jacobson TA
    Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis, rhabdomyolysis and multi-organ failure resulting from statin use.
    Rajaram M
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21686823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
    Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C
    J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Intensity Atorvastatin-Induced Rhabdomyolysis in an Elderly Patient With NSTEMI: A Case Report and Review of the Literature.
    Huynh GA; Lee AJ
    J Pharm Pract; 2017 Dec; 30(6):658-662. PubMed ID: 27798246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and myotoxicity: a therapeutic limitation.
    Tiwari A; Bansal V; Chugh A; Mookhtiar K
    Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
    Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
    Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.
    Zhou YT; Yu LS; Zeng S; Huang YW; Xu HM; Zhou Q
    Ther Clin Risk Manag; 2014; 10():17-26. PubMed ID: 24379677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal failure patient.
    Sica DA; Gehr TW
    Curr Opin Nephrol Hypertens; 2002 Mar; 11(2):123-33. PubMed ID: 11856903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopathy associated with atorvastatin-ezetimibe combination therapy.
    Weffald LA; Flach LA
    Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of atorvastatin after pediatric heart transplantation.
    Chin C; Gamberg P; Miller J; Luikart H; Bernstein D
    J Heart Lung Transplant; 2002 Nov; 21(11):1213-7. PubMed ID: 12431495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Statin-Induced Diplopia: An Often-Overlooked but Reported Side Effect.
    Abdelmasih R; Abdelmaseih R; Reed J
    Cureus; 2021 May; 13(5):e15117. PubMed ID: 34159019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
    Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyolysis in a Long-Term Statin User Without Traditional Risk Factors: A Case Report.
    Naritaka H; Aoki Y; Obata Y; Mimuro S; Nakajima Y
    Cureus; 2023 Sep; 15(9):e46069. PubMed ID: 37900543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.